Manufacturing Facilities and FDA Oversight Hospira operates manufacturing facilities in the United States, Australia, Italy, India, and several other countries
Conclusion The promotion and prescription of BPC-157 for musculoskeletal injuries without FDA approval is a troubling trend that poses significant risks to patients
Here are some tips: Rotate injection sites to avoid tissue damage
The moment you puncture the stopper of a sterile water vial, it is no longer considered sterile for future applications
While all components of a lipotropic injection generally have no side effects, you need to remember that all medications and supplements have potential side effects, including B12, methionine, inositol, choline, and amino acids
This product is not approved for human or veterinary use and is not a drug, dietary supplement, or cosmetic